ABSI Competitors & Alternatives
Compare Absci Corp with similar stocks in the same industry
Biotechnology
ABSI
Main Stock$8.40
Tradestie Score
55
Market Cap
$468.01M
Revenue Growth
-0.8%
Analyst Upside
+14.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$4.05
|
$1.22B | - | 54 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$5.38
|
$1.18B | - | 59 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$45.96
|
$1.17B | - | 61 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$22.67
|
$1.15B | 3.6 | 61 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$17.71
|
$1.14B | - | 62 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$8.93
|
$1.14B | - | 59 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$25.57
|
$1.13B | - | 51 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$6.17
|
$1.12B | - | 56 | Compare |
|
NKTR
Nektar Therapeutics
|
$65.70
|
$1.12B | - | 50 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$303.39
|
$1.12B | - | 59 | Compare |
More ABSI Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 8731)
220 stocks in this industry